Update on drug-related problems in the elderly

American Journal Geriatric Pharmacotherapy

Volumn 1, Issue 1, 2003, Pages 38-43

  Hanlon, Joseph T ^a,b,c   Lindblad, Catherine I ^a,c   Hajjar, Emily R ^a,c   McCarthy, Teresa C ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adverse drug reactions; Elderly; Prescribing

Indexed keywords

AMINOGLYCOSIDE; AMITRIPTYLINE; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; COTRIMOXAZOLE; DEXTROPROPOXYPHENE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; DIURETIC AGENT; HEPARIN; IMIPRAMINE; LEVOTHYROXINE; LITHIUM; METHOTREXATE; NALIDIXIC ACID; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; THEOPHYLLINE; TICLOPIDINE; TROGLITAZONE; UNINDEXED DRUG; DRUG;

AGED; ARTHRITIS; ASSISTED LIVING FACILITY; ASTHMA; DRUG INDUCED DISEASE; DRUG MISUSE; DRUG MONITORING; DRUG RELEASE; DRUG USE; DRUG UTILIZATION; GERIATRICS; HUMAN; KIDNEY FAILURE; MEDICAL RECORD; MEDLINE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; AGE; CLINICAL TRIAL; STATISTICS;

AGE FACTORS; AGED; CLINICAL TRIALS; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 2342441679     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1543-5946(03)80014-4     Document Type: Article

References (22)

1. Strand LM, Morley PC, Cipolle RJ, et al. Drug-related problems: Their structure and function. DICP. 1990;24:1093-1097.
2. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-1116.
3. Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc. 2002;50:26-34.
4. Sloane PD, Zimmerman S, Brown LC, et al. Inappropriate medication prescribing in residential care/assisted living facilities. J Am Geriatr Soc. 2002;50:1001-1011.
5. Hanlon JT, Fillenbaum GG, Kuchibhatla M, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care. 2002;40:166-176.
6. MacKinnon NJ, Hepler CD. Preventable drug-related morbidity in older adults: Indicator development. J Managed Care Pharm. 2002;8:365-371.
7. Morris CJ, Cantrill JA, Hepler CD, Noyce PR. Preventing drug-related morbidity - determining valid indicators. Int J Quality Health Care. 2002;14:183-198.
8. Robertson HA, MacKinnon NJ. Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adults. Clin Ther. 2002; 24:1595-1613.
9. Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drug reactions and related resource use. A study of community-dwelling persons 65 years of age and older. Ann Intern Med. 1992;117:634-640.
10. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997;45:945-948.
11. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-1564.
12. Hanlon JT, Maher R, Lindblad C, et al. Comparison of methods for detecting potential adverse drug events in frail elderly inpatients and outpatients. Am J Health Syst Pharm. 2001;58:1622-1626.
13. Classen D. Medication safety: Moving from illusion to reality. JAMA. 2003;289:1154-1156. Editorial.
14. Kessler DA. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. JAMA. 1993;269:2765-2768.
15. Venulet J, ten Ham M. Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther. 1996;34:112-129.
16. Blazer D, Hybels C, Simonsik E, Hanlon JT. Sedative, hypnotic and anti-anxiety medication use in an aging cohort over ten years: A racial comparison. J Am Geriatr Soc. 2000;48:1073-1079.
17. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157:1531-1536.
18. Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health. 1997;87:404-409.
19. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001;135:703-710.
20. Study of Clinically Relevant Indicators for Pharmacologic Therapy (SCRIPT). Available at: http://scriptproject.org/home.html. Accessed May 23, 2003.
21. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: A national consensus panel. CMAJ. 1997;156:385-391.
22. Appendix N. Surveyor procedures for pharmaceutical service requirements in long-term care facilities. In: State Operations Manual, Provider Certification. Dept of Health and Human Services, Health Care Financing Administration. Transmittal no. 242, September 1990. Available at: http://www.ascp.com/public/pr/2001/pdfs/App_N.pdf. Accessed May 23, 2003.